Page last updated: 2024-08-26

cyanopindolol and 1-methyl-3-isobutylxanthine

cyanopindolol has been researched along with 1-methyl-3-isobutylxanthine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Engelhardt, S; Hein, L; Kaumann, AJ; Lohse, M; Molenaar, P	1

Other Studies

1 other study(ies) available for cyanopindolol and 1-methyl-3-isobutylxanthine

Article	Year
Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology. Naunyn-Schmiedeberg's archives of pharmacology, 2001, Volume: 363, Issue:1 Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atrial Function; Binding, Competitive; Bucladesine; Dose-Response Relationship, Drug; Female; Genotype; Heart Atria; In Vitro Techniques; Isoproterenol; Male; Membranes; Mice; Mice, Knockout; Myocardial Contraction; Pindolol; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Sinoatrial Node; Tritium	2001

Article

Year

Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology.

Naunyn-Schmiedeberg's archives of pharmacology, 2001, Volume: 363, Issue:1

Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atrial Function; Binding, Competitive; Bucladesine; Dose-Response Relationship, Drug; Female; Genotype; Heart Atria; In Vitro Techniques; Isoproterenol; Male; Membranes; Mice; Mice, Knockout; Myocardial Contraction; Pindolol; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Sinoatrial Node; Tritium

2001